Choose your preferred way to stay informed of new case launches and settlement deadlines
The filed complaint alleges that AVITA Medical, Inc. made materially false and/or misleading statements and/or failed to disclose that: AVITA reported second quarter 2025 results and revised its 2025 guidance, stating that the Company experienced a “significant headwind from a temporary gap in Medicare Administrative Contractor (MAC) payments to providers for the use of our flagship RECELL® System, which led to a weakening in demand. Multiple MACs initiated payments in July with resolution expected in Q3.” Following this report, the price of the Company’s stock dropped on August 7, 2025.
In order to be eligible to join the RCEL class action lawsuit, you must have incurred a loss on shares of AVITA Medical, Inc. purchased during the class period listed above.
TOP
